Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Inspire IVF PCLBKK:IVF +2.70%18 Days Payable is 17.28 as of Mar. 2026, which is 68% below its 10-year median of 53.24. GuruFocus rates BKK:IVF with a GF Score™ of 18/100. The stock has 3 warning signs investors should review. Among 607 Healthcare Providers & Services companies, Inspire IVF PCL ranks worse than 82.37% on this metric.
The historical rank and industry rank for Inspire IVF PCL's Days Payable or its related term are showing as below:
BKK:IVF'
s Days Payable Range Over the Past 10 Years
Min: 20.02 Med: 53.24 Max: 117.47
Current: 21.71
During the past 5 years, Inspire IVF PCL's highest Days Payable was 117.47. The lowest was 20.02. And the median was 53.24.
BKK:IVF's Days Payable is ranked worse than 82.37% of 607
companies
in the Healthcare Providers & Services industry
Industry Median: 57.13
vs BKK:IVF: 21.71
Inspire IVF PCL's Days Payable
declined
from Mar. 2025 (24.35) to Mar. 2026 (17.28).
It may suggest that Inspire IVF PCLaccelerated paying its suppliers.
Inspire IVF PCL Days Payable Related Terms
Inspire IVF PCL Days Payable Historical Data
* Premium members only.
The historical data trend for Inspire IVF PCL's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Inspire IVF PCL's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Inspire IVF PCL Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Inspire IVF PCL's Days Payable distribution charts can be found below:
* The bar in red indicates where Inspire IVF PCL's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Inspire IVF PCL's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Inspire IVF PCL (BKK:IVF) has a Days Payable of 17.28 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Inspire IVF PCL and its competitors. This is 68% below median its historical median of 53.24. Over the past decade, Inspire IVF PCL's Days Payable has ranged from 20.02 to 117.47. According to the industry distribution chart, Inspire IVF PCL ranks #500 out of 607 companies in the Healthcare Providers & Services industry, placing it in the top 82.4%.
Is Inspire IVF PCL's Days Payable too high?
Inspire IVF PCL's current Days Payable of 17.28 is 68% below median its 10-year median of 53.24. Over the past 10 years, this metric has ranged from a low of 20.02 to a high of 117.47. The Healthcare Providers & Services industry median Days Payable is 57.13. Inspire IVF PCL's value of 17.28 is 69.8% below this industry median. Based on the distribution chart, Inspire IVF PCL ranks #500 out of 607 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Inspire IVF PCL has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Inspire IVF PCL's Days Payable compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Inspire IVF PCL ranks #500 out of 607 companies for Days Payable. This places Inspire IVF PCL in the lower half of its industry. The industry median Days Payable is 57.13. Inspire IVF PCL's value of 17.28 is 69.8% below this benchmark. Historically, Inspire IVF PCL's own Days Payable has ranged from 20.02 to 117.47 over the past decade. While the company's 10-year median is 53.24 vs. the industry median of 57.13, Inspire IVF PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 57.13, based on 607 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Inspire IVF PCL's current Days Payable of 17.28 is 69.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Inspire IVF PCL and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 57.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Inspire IVF PCL's current Days Payable is 17.28, which is 68% below median its own 10-year median of 53.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inspire IVF PCL stock overvalued right now?
Inspire IVF PCL (BKK:IVF) has a current Days Payable of 17.28. The current Days Payable is 17.28, which is 68% below median its 10-year median of 53.24 and 69.8% below the Healthcare Providers & Services industry median of 57.13. Inspire IVF PCL's overall GF Score™ is 18/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Inspire IVF PCL (BKK:IVF), the current Days Payable is 17.28 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Inspire IVF PCL operates a comprehensive fertility treatment center, offering services ranging from consultations to selecting the appropriate treatment for each couple. It is principally engaged in infertility treatment and counseling services treatment with anti-aging medicine and health restoration, hemodialysis, blood filtration, and plasma filtration. The company operates in a single geographic area, Thailand.
18GF Score
Get the complete analysis for BKK:IVF
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:IVF has been successfully added to your 
